Cargando…
Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
New platforms are needed for the design of novel prophylactic vaccines and advanced immune therapies. Live-attenuated yellow fever vaccine YF17D serves as a vector for several licensed vaccines and platform for novel candidates. On the basis of YF17D, we developed an exceptionally potent COVID-19 va...
Autores principales: | Li, Li-Hsin, Liesenborghs, Laurens, Wang, Lanjiao, Lox, Marleen, Yakass, Michael Bright, Jansen, Sander, Rosales Rosas, Ana Lucia, Zhang, Xin, Thibaut, Hendrik Jan, Teuwen, Dirk, Neyts, Johan, Delang, Leen, Dallmeier, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925082/ https://www.ncbi.nlm.nih.gov/pubmed/35313504 http://dx.doi.org/10.1016/j.omtm.2022.03.010 |
Ejemplares similares
-
Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models
por: Ma, Ji, et al.
Publicado: (2022) -
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge
por: Lemmens, Viktor, et al.
Publicado: (2023) -
Ex vivo gut cultures of Aedes aegypti are efficiently infected by mosquito-borne alpha- and flaviviruses
por: Rosales Rosas, Ana Lucia, et al.
Publicado: (2023) -
Understanding the Mechanisms Underlying Host Restriction of Insect-Specific Viruses
por: Elrefaey, Ahmed ME, et al.
Publicado: (2020) -
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
por: Claes, Jorien, et al.
Publicado: (2015)